Crossmark

Patient, target, device, and program selection for DBS in Parkinson’s disease: advancing toward precision care

Published Online: 2025-07-01

Authors

Wagle Shukla, Aparna

Bange, Manuel https://orcid.org/0000-0002-5247-8810
Muthuraman, Muthuraman
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 3 June 2024

Accepted: 22 May 2025

First Online: 1 July 2025

Competing interests

: A.W.S. reports grant support from the NIH R01NS122943 as PI and Ro1 NS121120-01 as a Co-I. She reports past funding from Benign Essential Blepharospasm Research foundation, Dystonia coalition, Dystonia Medical Research foundation, National Organization for Rare Disorders. AWS has received consultant fees from Merz, Jazz and Acadia. She is the current Vice President for the Tremor Research Group and recent advisor for Supernus, Biogen-Sage and Encora. AWS and MM are currently serving as the associate editors for Nature Parkinson’ disease journal.

Document is current